Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LAZERTINIB for Product used for unknown indication: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 114 adverse event reports in the FDA FAERS database where LAZERTINIB was used for Product used for unknown indication.

Most Reported Side Effects for LAZERTINIB

Side Effect Reports % Deaths Hosp.
Rash 77 21.9% 0 3
Neuropathy peripheral 32 9.1% 0 0
Infusion related reaction 30 8.5% 1 6
Fatigue 26 7.4% 2 4
Diarrhoea 20 5.7% 0 4
Off label use 19 5.4% 0 5
Paronychia 16 4.6% 0 1
Pruritus 13 3.7% 0 0
Nausea 12 3.4% 1 2
Dyspnoea 11 3.1% 1 2
Oedema peripheral 11 3.1% 0 4
Hypoaesthesia 10 2.8% 0 1
Stomatitis 10 2.8% 0 1
Decreased appetite 9 2.6% 0 0
Non-small cell lung cancer 9 2.6% 1 1

Other Indications for LAZERTINIB

Non-small cell lung cancer (133) Lung neoplasm malignant (44) Non-small cell lung cancer metastatic (16) Egfr gene mutation (12) Lung adenocarcinoma stage iv (6) Lung carcinoma cell type unspecified recurrent (5)

Other Drugs Used for Product used for unknown indication

OXYCODONE (129,391) ADAPALENE (91,681) APIXABAN (88,417) ETANERCEPT (71,866) SACUBITRIL\VALSARTAN (69,693) ACETAMINOPHEN (68,427) AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206) ADALIMUMAB (63,549) EVOLOCUMAB (60,696) MORPHINE (59,440)

Related Pages

LAZERTINIB Full Profile All Product used for unknown indication Drugs LAZERTINIB Demographics LAZERTINIB Timeline